IN2012DN05145A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN05145A IN2012DN05145A IN5145DEN2012A IN2012DN05145A IN 2012DN05145 A IN2012DN05145 A IN 2012DN05145A IN 5145DEN2012 A IN5145DEN2012 A IN 5145DEN2012A IN 2012DN05145 A IN2012DN05145 A IN 2012DN05145A
- Authority
- IN
- India
- Prior art keywords
- polypeptides
- peptides
- compositions
- fusion
- polypeptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 17
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 16
- 229920001184 polypeptide Polymers 0.000 abstract 12
- 230000004927 fusion Effects 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 4
- 108010006785 Taq Polymerase Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Virology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26291909P | 2009-11-19 | 2009-11-19 | |
US35045710P | 2010-06-01 | 2010-06-01 | |
US35654110P | 2010-06-18 | 2010-06-18 | |
US39085710P | 2010-10-07 | 2010-10-07 | |
PCT/IB2010/003127 WO2011061625A2 (en) | 2009-11-19 | 2010-11-19 | Compositions for increasing polypeptide stability and activity, and related methods |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN05145A true IN2012DN05145A (ko) | 2015-10-23 |
Family
ID=43902655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN5145DEN2012 IN2012DN05145A (ko) | 2009-11-19 | 2010-11-19 |
Country Status (9)
Country | Link |
---|---|
US (5) | US9321999B2 (ko) |
EP (3) | EP2905332B1 (ko) |
KR (4) | KR101773636B1 (ko) |
CN (1) | CN102858962A (ko) |
CA (1) | CA2780678A1 (ko) |
DK (1) | DK2501716T3 (ko) |
ES (1) | ES2533536T3 (ko) |
IN (1) | IN2012DN05145A (ko) |
WO (1) | WO2011061625A2 (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011061625A2 (en) | 2009-11-19 | 2011-05-26 | Solis Biodyne | Compositions for increasing polypeptide stability and activity, and related methods |
UA115657C2 (uk) * | 2011-09-19 | 2017-12-11 | Аксон Ньюросайєнс Сє | Виділене антитіло, яке зв'язується з одним або декількома епітопами тау, фармацевтична композиція, що його містить, спосіб лікування та спосіб діагностики хвороби альцгеймера на основі виділеного антитіла |
EP3366769B1 (en) * | 2012-10-16 | 2021-02-17 | DNA Polymerase Technology, Inc. | Inhibition-resistant polymerases |
KR101503726B1 (ko) * | 2013-04-30 | 2015-03-19 | (주)진매트릭스 | Dna 제한효소에 의해 활성 조절이 가능한 프라이머 및 이를 이용한 유전자 증폭방법 그리고 이러한 프라이머의 설계방법 |
CN104004857B (zh) * | 2014-05-27 | 2015-10-28 | 广州博至生物科技有限公司 | 一种快速区分不同基因型犬细小病毒的pcr-hrm引物和方法 |
US11091745B2 (en) | 2015-05-12 | 2021-08-17 | Dna Polymerase Technology, Inc. | Mutant polymerases and uses thereof |
CN106319092B (zh) * | 2016-09-27 | 2018-03-09 | 广州维佰生物科技有限公司 | 一种快速鉴别猪流行性腹泻病毒经典株与变异株的hrm检测引物、试剂盒及方法 |
CN106754816B (zh) * | 2017-02-24 | 2020-10-27 | 依科赛生物科技(太仓)有限公司 | 一种高保真快速扩增融合酶及其制备方法 |
CN109628423A (zh) * | 2018-12-06 | 2019-04-16 | 北京春雷杰创生物科技有限公司 | 一种热启动Taq DNA聚合酶组合优化分子试剂的方法 |
CN113391067B (zh) * | 2021-06-16 | 2023-07-25 | 军事科学院军事医学研究院军事兽医研究所 | 抗尼帕病毒g蛋白抗体的间接elisa检测方法 |
CN113720941B (zh) * | 2021-09-18 | 2023-03-24 | 广东丸美生物技术股份有限公司 | 护肤品原料或者护肤品中多肽的检测方法及多肽的高效液相色谱检测方法 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3625214A (en) | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4906474A (en) | 1983-03-22 | 1990-03-06 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4789734A (en) | 1985-08-06 | 1988-12-06 | La Jolla Cancer Research Foundation | Vitronectin specific cell receptor derived from mammalian mesenchymal tissue |
ATE88761T1 (de) | 1986-01-10 | 1993-05-15 | Amoco Corp | Kompetitiver homogener test. |
US4925673A (en) | 1986-08-18 | 1990-05-15 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
US5322770A (en) | 1989-12-22 | 1994-06-21 | Hoffman-Laroche Inc. | Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription |
US4889818A (en) | 1986-08-22 | 1989-12-26 | Cetus Corporation | Purified thermostable enzyme |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US5811128A (en) | 1986-10-24 | 1998-09-22 | Southern Research Institute | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor |
US6090591A (en) | 1987-07-31 | 2000-07-18 | The Board Of Trustees Of The Leland Stanford Junior University | Selective amplification of target polynucleotide sequences |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
JP2650159B2 (ja) | 1988-02-24 | 1997-09-03 | アクゾ・ノベル・エヌ・ベー | 核酸増幅方法 |
CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
DE69034177T2 (de) | 1989-07-11 | 2005-10-27 | Gen-Probe Inc., San Diego | Verfahren zur Amplifikation von Nukleinsäuresequenzen |
CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
US5194370A (en) | 1990-05-16 | 1993-03-16 | Life Technologies, Inc. | Promoter ligation activated transcription amplification of nucleic acid sequences |
TW279133B (ko) | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
US6060069A (en) | 1991-05-20 | 2000-05-09 | Dura Pharmaceuticals, Inc. | Pulmonary delivery of pharmaceuticals |
US5169766A (en) | 1991-06-14 | 1992-12-08 | Life Technologies, Inc. | Amplification of nucleic acid molecules |
EP0670730B1 (en) | 1992-03-30 | 2003-06-04 | Immunex Corporation | Fusion protein comprising two tumor necrosis factor receptors |
CA2135073C (en) | 1992-05-06 | 2002-11-19 | Daniel L. Kacian | Nucleic acid sequence amplification method, composition and kit |
DK0652973T3 (da) | 1992-07-31 | 1997-09-15 | Behringwerke Ag | Fremgangsmåde til indføring af definerede sekvenser ved 3-enden af polynukleotider |
US5338671A (en) | 1992-10-07 | 1994-08-16 | Eastman Kodak Company | DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody |
EP0678034B1 (en) | 1993-01-11 | 1999-05-26 | Dana Farber Cancer Institute | Inducing cytotoxic t lymphocyte responses |
US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
US5997501A (en) | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
JP3189000B2 (ja) | 1994-12-01 | 2001-07-16 | 東ソー株式会社 | 特定核酸配列の検出方法 |
US5656284A (en) | 1995-04-24 | 1997-08-12 | Balkin; Michael S. | Oral transmucosal delivery tablet and method of making it |
US5710029A (en) | 1995-06-07 | 1998-01-20 | Gen-Probe Incorporated | Methods for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product |
US5773258A (en) | 1995-08-25 | 1998-06-30 | Roche Molecular Systems, Inc. | Nucleic acid amplification using a reversibly inactivated thermostable enzyme |
CA2232378C (en) | 1995-09-19 | 2009-04-14 | Fujisawa Pharmaceutical Co., Ltd. | Aerosol compositions |
US5928682A (en) | 1995-12-21 | 1999-07-27 | Johnson & Johnson Vision Products, Inc. | Annular gated mold for the injection molding of contact lenses |
EP0892808B1 (en) | 1996-04-12 | 2008-05-14 | PHRI Properties, Inc. | Detection probes, kits and assays |
US5830714A (en) | 1996-04-17 | 1998-11-03 | Molecular Biology Resources, Inc. | Biologically active fragment of bacillus stearothermophilus DNA polymerase |
US6016800A (en) | 1997-10-24 | 2000-01-25 | Century; Theodore J. | Intrapulmonary aerosolizer |
EP1037687B8 (en) | 1997-12-11 | 2008-10-22 | Alza Corporation | Device for enhancing transdermal agent flux |
US6365346B1 (en) | 1998-02-18 | 2002-04-02 | Dade Behring Inc. | Quantitative determination of nucleic acid amplification products |
US6183998B1 (en) | 1998-05-29 | 2001-02-06 | Qiagen Gmbh Max-Volmer-Strasse 4 | Method for reversible modification of thermostable enzymes |
US6348210B1 (en) | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
US6375975B1 (en) | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
US6284262B1 (en) | 1999-01-26 | 2001-09-04 | Virgil A. Place | Compact dosage unit for buccal administration of a pharmacologically active agent |
US6303305B1 (en) | 1999-03-30 | 2001-10-16 | Roche Diagnostics, Gmbh | Method for quantification of an analyte |
DE60014762T2 (de) | 1999-05-24 | 2005-10-13 | Tosoh Corp., Shinnanyo | Methode zum Nachweis von Ribonukleinsäuren |
US6917726B2 (en) | 2001-09-27 | 2005-07-12 | Cornell Research Foundation, Inc. | Zero-mode clad waveguides for performing spectroscopy with confined effective observation volumes |
US6627424B1 (en) * | 2000-05-26 | 2003-09-30 | Mj Bioworks, Inc. | Nucleic acid modifying enzymes |
CA2421303A1 (en) * | 2000-09-13 | 2002-03-21 | Smithkline Beecham Corporation | Novel compounds |
EP2314698A1 (en) | 2002-06-14 | 2011-04-27 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
EP2325303B1 (en) * | 2002-09-13 | 2013-11-06 | Life Technologies Corporation | Thermostable reverse transcriptases and uses thereof |
US6814279B2 (en) * | 2002-10-23 | 2004-11-09 | Jochens James M | Cricket box |
US7267673B2 (en) | 2002-12-12 | 2007-09-11 | Pacific Biosciences Laboratories, Inc. | System for treatment of acne skin condition using a narrow band light source |
AU2004203649B2 (en) * | 2003-08-12 | 2006-01-12 | F. Hoffmann-La Roche Ag | Thermostable Taq polymerase fragment |
US7170050B2 (en) | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
US7601498B2 (en) | 2005-03-17 | 2009-10-13 | Biotium, Inc. | Methods of using dyes in association with nucleic acid staining or detection and associated technology |
KR101275950B1 (ko) * | 2008-05-29 | 2013-06-25 | 한올바이오파마주식회사 | 증가된 단백질분해효소 저항성을 나타내는 변형된 에리스로포이에틴(epo) 폴리펩티드 및 이의 약제학적 조성물 |
WO2011061625A2 (en) | 2009-11-19 | 2011-05-26 | Solis Biodyne | Compositions for increasing polypeptide stability and activity, and related methods |
US8910915B2 (en) | 2011-06-21 | 2014-12-16 | Otter Products, Llc | Folding stand and cover |
-
2010
- 2010-11-19 WO PCT/IB2010/003127 patent/WO2011061625A2/en active Application Filing
- 2010-11-19 KR KR1020127015034A patent/KR101773636B1/ko active IP Right Grant
- 2010-11-19 EP EP14198178.7A patent/EP2905332B1/en active Active
- 2010-11-19 DK DK10803492.7T patent/DK2501716T3/en active
- 2010-11-19 KR KR1020177023312A patent/KR20170098985A/ko active Search and Examination
- 2010-11-19 IN IN5145DEN2012 patent/IN2012DN05145A/en unknown
- 2010-11-19 CA CA2780678A patent/CA2780678A1/en not_active Abandoned
- 2010-11-19 EP EP10803492.7A patent/EP2501716B1/en active Active
- 2010-11-19 CN CN2010800610407A patent/CN102858962A/zh active Pending
- 2010-11-19 KR KR1020187033851A patent/KR102078756B1/ko active IP Right Grant
- 2010-11-19 US US12/950,349 patent/US9321999B2/en active Active
- 2010-11-19 ES ES10803492.7T patent/ES2533536T3/es active Active
- 2010-11-19 EP EP18186578.3A patent/EP3461889A1/en active Pending
- 2010-11-19 KR KR1020207004032A patent/KR102177195B1/ko active IP Right Grant
-
2016
- 2016-03-11 US US15/068,477 patent/US9816078B2/en active Active
-
2017
- 2017-10-09 US US15/728,344 patent/US20180245056A1/en not_active Abandoned
-
2019
- 2019-09-13 US US16/570,157 patent/US11118169B2/en active Active
-
2021
- 2021-08-06 US US17/395,800 patent/US20220090034A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2905332B1 (en) | 2018-09-12 |
EP3461889A1 (en) | 2019-04-03 |
KR20120109500A (ko) | 2012-10-08 |
KR102177195B1 (ko) | 2020-11-11 |
US11118169B2 (en) | 2021-09-14 |
US20110142792A1 (en) | 2011-06-16 |
KR20200018726A (ko) | 2020-02-19 |
CN102858962A (zh) | 2013-01-02 |
ES2533536T3 (es) | 2015-04-10 |
KR102078756B1 (ko) | 2020-02-19 |
EP2501716A2 (en) | 2012-09-26 |
WO2011061625A2 (en) | 2011-05-26 |
CA2780678A1 (en) | 2011-05-26 |
US20220090034A1 (en) | 2022-03-24 |
US20180245056A1 (en) | 2018-08-30 |
US9816078B2 (en) | 2017-11-14 |
US20160251637A1 (en) | 2016-09-01 |
DK2501716T3 (en) | 2015-04-07 |
EP2501716B1 (en) | 2015-01-21 |
KR20170098985A (ko) | 2017-08-30 |
KR101773636B1 (ko) | 2017-09-01 |
WO2011061625A3 (en) | 2011-07-14 |
US20200172883A1 (en) | 2020-06-04 |
KR20180128086A (ko) | 2018-11-30 |
EP2905332A1 (en) | 2015-08-12 |
US9321999B2 (en) | 2016-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN05145A (ko) | ||
MX2010008696A (es) | Composiciones de proteina estabilizadas. | |
MX360741B (es) | Constructos de polipéptidos y sus usos. | |
AU2017248121A1 (en) | T cell receptors | |
AU2017248120A1 (en) | T cell receptors | |
NZ731571A (en) | T cell receptors | |
WO2010034032A3 (en) | Methods for preparing purified polypeptide compositions | |
MY161534A (en) | Methods of purifying polypeptides | |
WO2010062779A3 (en) | Modified dna polymerases | |
MY162737A (en) | 4-1bb binding molecules | |
MY201293A (en) | Chimeric factor viii polypeptides and uses thereof | |
UA107329C2 (uk) | Туберкульозний білок rv2386c, композиція, що його містить, та застосування | |
NZ592420A (en) | Cd86 antagonist multi-target binding proteins | |
WO2008059252A3 (en) | Methods and composition fro t cell receptors which recognize 5t4 antigen | |
WO2013040093A3 (en) | Glucagon-like peptide-2 compositions and methods of making and using same | |
WO2009036448A3 (en) | Natriuretic peptide receptor-c agonists | |
NZ706884A (en) | Fc gamma receptor iib variants | |
MX346950B (es) | Reovirus que tienen secuencias modificadas. | |
WO2011021194A3 (en) | Pericyte progenitor cells and methods of generating and using same | |
MX350126B (es) | Polipéptido aislado de las proteínas de la toxina a y la toxina b de c. difficile y usos del mismo. | |
WO2010014830A3 (en) | Peptide therapeutics that bind vegf and methods of use thereof | |
AU2011353197A8 (en) | A cross linking polypeptide comprising an hexameric single chain antibody binding MHC-MAGE complex that induces apoptosis | |
MX2010002769A (es) | Preparacion recombinante de fracciones de bromelaina seleccionadas. | |
MY161268A (en) | PEPTIDE OR PEPTIDE COMPLEX BINDING TO α2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME | |
MX2010010457A (es) | Vectores recombinantes de rinovirus. |